Back to Journals » Drug Design, Development and Therapy » Volume 14

The Activity and Safety of Anlotinib for Patients with Extremity Desmoid Fibromatosis: A Retrospective Study in a Single Institution

Total article views   HTML views PDF downloads Totals
5,650 Dovepress* 5,387+ 878 6,265
PubMed Central* 263 127 390
Totals 5,650 1,005 6,655
*Since 25 September 2020

View citations on PubMed and Google Scholar